Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP1 | P07148 | 1/20 | 1.00 |
| ▸ | FABP6 | P51161 | 1/20 | 1.00 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | NOS2 | P35228 | 1/20 | 0.61 |
| ▸ | NOS1 | P29475 | 1/20 | 0.58 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2230559 | 1.00 | FABP1 (1.00) | FABP1FABP6CXCR4KDM4ENPC1 | |
| Fluoride SCHEMBL28270594 | 0.98 | FABP1 (0.96) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL27585010 | 0.98 | FABP1 (0.96) | FABP1FABP6CXCR4KDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL4696844 | 0.98 | FABP1 (0.96) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL29351380 | 0.94 | CXCR4 (1.00) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL589266 | 0.94 | CXCR4 (1.00) | FABP1FABP6CXCR4KDM4ENPC1 | |
| Alcohol SCHEMBL11700176 | 0.91 | FABP1 (0.83) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL3374151 | 0.89 | CXCR4 (0.82) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL10054969 | 0.88 | FABP1 (0.79) | FABP1FABP6CXCR4KDM4ENPC1 | |
| SCHEMBL10055030 | 0.88 | CXCR4 (0.89) | FABP1FABP6CXCR4KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586893-B1 | COPPER PLATING BATH AND CORRESPONDING METHOD | ROHM & HAAS ELECT MAT (US) | 2022-09-21 | — | — | EP | claimed |
| EP-3906233-B1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL MED MOUNT SINAI (US) | 2024-01-31 | — | — | EP | disclosed |
| CN-116606292-A | Pyrido [1,2-a ] pyrimidinone derivatives containing sulfonamide unit, preparation method and application thereof | 贵州大学 | 2023-08-18 | — | — | CN | disclosed |
| EP-3680230-B1 | HYPOCRELLIN DERIVATIVE SUBSTITUTED BOTH IN A PERI-POSITION AND IN 2-POSITION BY AMINO, PREPARATION METHOD, AND APPLICATION THEREOF | TECHNICAL INST OF PHYSICS AND CHEMISTRY OF THE CHINESE ACADEMY OF SCIENCES (CN) | 2022-11-02 | — | — | EP | disclosed |
| US-11439707-B2 | Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof | Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences (CN) | 2022-09-13 | — | — | US | disclosed |
| US-20220162182-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162182-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | MAP3K20, MAP3K1, PACSIN2 | FABP1 3846/4885FABP6 3480/4885CXCR4 1916/4885 |
| US-11439707-B2 | Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof | PPOX, AAAS, HCCS | FABP1 4874/4885FABP6 4508/4885CXCR4 3772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.